GABA acts as a ligand chaperone in the early secretory pathway to promote cell surface expression of GABAA receptors

This publication has 83 references indexed in Scilit:

• Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs
  Trends in Endocrinology & Metabolism, 2010
• Functional Rescue of β₁‐Adrenoceptor Dimerization and Trafficking by Pharmacological Chaperones
  Traffic, 2009
• Nicotine Normalizes Intracellular Subunit Stoichiometry of Nicotinic Receptors Carrying Mutations Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
  Molecular Pharmacology, 2009
• Glutamate Binding and Conformational Flexibility of Ligand-binding Domains Are Critical Early Determinants of Efficient Kainate Receptor Biogenesis
  Journal of Biological Chemistry, 2009
• Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug Discovery
  The AAPS Journal, 2009
• GABAA receptor trafficking and its role in the dynamic modulation of neuronal inhibition
  Nature Reviews Neuroscience, 2008
• Glutamate Receptor Dynamics in Dendritic Microdomains
  Neuron, 2008
• Nonvesicular Inhibitory Neurotransmission via Reversal of the GABA Transporter GAT-1
  Neuron, 2007
• Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor
  The EMBO Journal, 2007
• Pharmacological chaperones: potential treatment for conformational diseases
  Trends in Endocrinology & Metabolism, 2004